Cardiovascular Diabetology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2257331, encodeId=ab7e225e331f0, content=审稿速度:1.0 偏重的研究方向：心血管;糖尿病 经验分享：想问一下大家，这个文章外审后给了拒稿重投，还有必要大修完投回去吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1f6389102, createdName=ms1000000152514518, createdTime=Sat Mar 22 23:40:45 CST 2025, time=2025-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254269, encodeId=217322542692e, content=偏重的研究方向：心血管;糖尿病 经验分享：请问各位大佬，1）收到邮件通知文章接收，大概多久会收到支付版面费的邮件呢？2）另外，基金号不小心带错了，可以在校稿的时候修改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sun Mar 02 17:50:58 CST 2025, time=2025-03-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2144587, encodeId=c7a0214458e9d, content=有幸中了一篇，从投稿到接受1月零2天，整体比较顺，杂志对统计要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=667, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Sun Jun 25 09:03:13 CST 2023, time=2023-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198288, encodeId=bebf219828868, content=偏重的研究方向：代谢综合征 经验分享：请问各位大佬，peer review是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eb18429497, createdName=ms5000001142047044, createdTime=Sat Apr 13 15:04:33 CST 2024, time=2024-04-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2235750, encodeId=3a2d2235e506c, content=请问大家这个期刊如果审稿了，是不是大概率会接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/d5f470c5d4004705a6d8acee50b9c447-590mWyVcWjZT.jpg, createdBy=f66e9407848, createdName=非我, createdTime=Thu Nov 07 20:21:00 CST 2024, time=2024-11-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230586, encodeId=a70d2230586ed, content=审稿速度:1.0 经验分享：还愿来了，第一篇基础文章接受，投稿后几天通过技术检查，然后秒送外审，审稿一个月返回，审稿人没有让补实验，修回几天后就接收了。做的糖尿病心肌病+铁死亡，感觉是编辑比较认可文章，审稿人可能就是还行。祝大家好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Sun Oct 13 10:20:37 CST 2024, time=2024-10-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234559, encodeId=bf6b22345590e, content=编辑邀请了13个审稿人但是半个月了无人接单。。大家都是多久有审稿人接单的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Fri Nov 01 14:28:26 CST 2024, time=2024-11-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205407, encodeId=8acd220540ec2, content=技术审查都一周了，还没到编辑那里，你们的多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38265396482, createdName=ms9000000045361890, createdTime=Sat May 18 21:20:40 CST 2024, time=2024-05-18, status=1, ipAttribution=安徽省)]

2025-03-22 ms1000000152514518 来自广东省

审稿速度:1.0
偏重的研究方向：心血管;糖尿病
经验分享：想问一下大家，这个文章外审后给了拒稿重投，还有必要大修完投回去吗

10 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257331, encodeId=ab7e225e331f0, content=审稿速度:1.0 偏重的研究方向：心血管;糖尿病 经验分享：想问一下大家，这个文章外审后给了拒稿重投，还有必要大修完投回去吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1f6389102, createdName=ms1000000152514518, createdTime=Sat Mar 22 23:40:45 CST 2025, time=2025-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254269, encodeId=217322542692e, content=偏重的研究方向：心血管;糖尿病 经验分享：请问各位大佬，1）收到邮件通知文章接收，大概多久会收到支付版面费的邮件呢？2）另外，基金号不小心带错了，可以在校稿的时候修改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sun Mar 02 17:50:58 CST 2025, time=2025-03-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2144587, encodeId=c7a0214458e9d, content=有幸中了一篇，从投稿到接受1月零2天，整体比较顺，杂志对统计要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=667, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Sun Jun 25 09:03:13 CST 2023, time=2023-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198288, encodeId=bebf219828868, content=偏重的研究方向：代谢综合征 经验分享：请问各位大佬，peer review是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eb18429497, createdName=ms5000001142047044, createdTime=Sat Apr 13 15:04:33 CST 2024, time=2024-04-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2235750, encodeId=3a2d2235e506c, content=请问大家这个期刊如果审稿了，是不是大概率会接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/d5f470c5d4004705a6d8acee50b9c447-590mWyVcWjZT.jpg, createdBy=f66e9407848, createdName=非我, createdTime=Thu Nov 07 20:21:00 CST 2024, time=2024-11-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230586, encodeId=a70d2230586ed, content=审稿速度:1.0 经验分享：还愿来了，第一篇基础文章接受，投稿后几天通过技术检查，然后秒送外审，审稿一个月返回，审稿人没有让补实验，修回几天后就接收了。做的糖尿病心肌病+铁死亡，感觉是编辑比较认可文章，审稿人可能就是还行。祝大家好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Sun Oct 13 10:20:37 CST 2024, time=2024-10-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234559, encodeId=bf6b22345590e, content=编辑邀请了13个审稿人但是半个月了无人接单。。大家都是多久有审稿人接单的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Fri Nov 01 14:28:26 CST 2024, time=2024-11-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205407, encodeId=8acd220540ec2, content=技术审查都一周了，还没到编辑那里，你们的多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38265396482, createdName=ms9000000045361890, createdTime=Sat May 18 21:20:40 CST 2024, time=2024-05-18, status=1, ipAttribution=安徽省)]

2025-03-02 清清欢来自江西省

偏重的研究方向：心血管;糖尿病
经验分享：请问各位大佬，1）收到邮件通知文章接收，大概多久会收到支付版面费的邮件呢？2）另外，基金号不小心带错了，可以在校稿的时候修改吗？

120 0

[GetPortalCommentsPageByObjectIdResponse(id=2257331, encodeId=ab7e225e331f0, content=审稿速度:1.0 偏重的研究方向：心血管;糖尿病 经验分享：想问一下大家，这个文章外审后给了拒稿重投，还有必要大修完投回去吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1f6389102, createdName=ms1000000152514518, createdTime=Sat Mar 22 23:40:45 CST 2025, time=2025-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254269, encodeId=217322542692e, content=偏重的研究方向：心血管;糖尿病 经验分享：请问各位大佬，1）收到邮件通知文章接收，大概多久会收到支付版面费的邮件呢？2）另外，基金号不小心带错了，可以在校稿的时候修改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sun Mar 02 17:50:58 CST 2025, time=2025-03-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2144587, encodeId=c7a0214458e9d, content=有幸中了一篇，从投稿到接受1月零2天，整体比较顺，杂志对统计要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=667, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Sun Jun 25 09:03:13 CST 2023, time=2023-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198288, encodeId=bebf219828868, content=偏重的研究方向：代谢综合征 经验分享：请问各位大佬，peer review是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eb18429497, createdName=ms5000001142047044, createdTime=Sat Apr 13 15:04:33 CST 2024, time=2024-04-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2235750, encodeId=3a2d2235e506c, content=请问大家这个期刊如果审稿了，是不是大概率会接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/d5f470c5d4004705a6d8acee50b9c447-590mWyVcWjZT.jpg, createdBy=f66e9407848, createdName=非我, createdTime=Thu Nov 07 20:21:00 CST 2024, time=2024-11-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230586, encodeId=a70d2230586ed, content=审稿速度:1.0 经验分享：还愿来了，第一篇基础文章接受，投稿后几天通过技术检查，然后秒送外审，审稿一个月返回，审稿人没有让补实验，修回几天后就接收了。做的糖尿病心肌病+铁死亡，感觉是编辑比较认可文章，审稿人可能就是还行。祝大家好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Sun Oct 13 10:20:37 CST 2024, time=2024-10-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234559, encodeId=bf6b22345590e, content=编辑邀请了13个审稿人但是半个月了无人接单。。大家都是多久有审稿人接单的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Fri Nov 01 14:28:26 CST 2024, time=2024-11-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205407, encodeId=8acd220540ec2, content=技术审查都一周了，还没到编辑那里，你们的多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38265396482, createdName=ms9000000045361890, createdTime=Sat May 18 21:20:40 CST 2024, time=2024-05-18, status=1, ipAttribution=安徽省)]

2023-06-25 ms8000001858743317 来自北京

有幸中了一篇，从投稿到接受1月零2天，整体比较顺，杂志对统计要求较高

667 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257331, encodeId=ab7e225e331f0, content=审稿速度:1.0 偏重的研究方向：心血管;糖尿病 经验分享：想问一下大家，这个文章外审后给了拒稿重投，还有必要大修完投回去吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1f6389102, createdName=ms1000000152514518, createdTime=Sat Mar 22 23:40:45 CST 2025, time=2025-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254269, encodeId=217322542692e, content=偏重的研究方向：心血管;糖尿病 经验分享：请问各位大佬，1）收到邮件通知文章接收，大概多久会收到支付版面费的邮件呢？2）另外，基金号不小心带错了，可以在校稿的时候修改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sun Mar 02 17:50:58 CST 2025, time=2025-03-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2144587, encodeId=c7a0214458e9d, content=有幸中了一篇，从投稿到接受1月零2天，整体比较顺，杂志对统计要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=667, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Sun Jun 25 09:03:13 CST 2023, time=2023-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198288, encodeId=bebf219828868, content=偏重的研究方向：代谢综合征 经验分享：请问各位大佬，peer review是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eb18429497, createdName=ms5000001142047044, createdTime=Sat Apr 13 15:04:33 CST 2024, time=2024-04-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2235750, encodeId=3a2d2235e506c, content=请问大家这个期刊如果审稿了，是不是大概率会接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/d5f470c5d4004705a6d8acee50b9c447-590mWyVcWjZT.jpg, createdBy=f66e9407848, createdName=非我, createdTime=Thu Nov 07 20:21:00 CST 2024, time=2024-11-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230586, encodeId=a70d2230586ed, content=审稿速度:1.0 经验分享：还愿来了，第一篇基础文章接受，投稿后几天通过技术检查，然后秒送外审，审稿一个月返回，审稿人没有让补实验，修回几天后就接收了。做的糖尿病心肌病+铁死亡，感觉是编辑比较认可文章，审稿人可能就是还行。祝大家好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Sun Oct 13 10:20:37 CST 2024, time=2024-10-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234559, encodeId=bf6b22345590e, content=编辑邀请了13个审稿人但是半个月了无人接单。。大家都是多久有审稿人接单的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Fri Nov 01 14:28:26 CST 2024, time=2024-11-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205407, encodeId=8acd220540ec2, content=技术审查都一周了，还没到编辑那里，你们的多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38265396482, createdName=ms9000000045361890, createdTime=Sat May 18 21:20:40 CST 2024, time=2024-05-18, status=1, ipAttribution=安徽省)]

2024-04-13 ms5000001142047044 来自山东省

偏重的研究方向：代谢综合征
经验分享：请问各位大佬，peer review是送审了吗

218 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257331, encodeId=ab7e225e331f0, content=审稿速度:1.0 偏重的研究方向：心血管;糖尿病 经验分享：想问一下大家，这个文章外审后给了拒稿重投，还有必要大修完投回去吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1f6389102, createdName=ms1000000152514518, createdTime=Sat Mar 22 23:40:45 CST 2025, time=2025-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254269, encodeId=217322542692e, content=偏重的研究方向：心血管;糖尿病 经验分享：请问各位大佬，1）收到邮件通知文章接收，大概多久会收到支付版面费的邮件呢？2）另外，基金号不小心带错了，可以在校稿的时候修改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sun Mar 02 17:50:58 CST 2025, time=2025-03-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2144587, encodeId=c7a0214458e9d, content=有幸中了一篇，从投稿到接受1月零2天，整体比较顺，杂志对统计要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=667, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Sun Jun 25 09:03:13 CST 2023, time=2023-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198288, encodeId=bebf219828868, content=偏重的研究方向：代谢综合征 经验分享：请问各位大佬，peer review是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eb18429497, createdName=ms5000001142047044, createdTime=Sat Apr 13 15:04:33 CST 2024, time=2024-04-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2235750, encodeId=3a2d2235e506c, content=请问大家这个期刊如果审稿了，是不是大概率会接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/d5f470c5d4004705a6d8acee50b9c447-590mWyVcWjZT.jpg, createdBy=f66e9407848, createdName=非我, createdTime=Thu Nov 07 20:21:00 CST 2024, time=2024-11-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230586, encodeId=a70d2230586ed, content=审稿速度:1.0 经验分享：还愿来了，第一篇基础文章接受，投稿后几天通过技术检查，然后秒送外审，审稿一个月返回，审稿人没有让补实验，修回几天后就接收了。做的糖尿病心肌病+铁死亡，感觉是编辑比较认可文章，审稿人可能就是还行。祝大家好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Sun Oct 13 10:20:37 CST 2024, time=2024-10-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234559, encodeId=bf6b22345590e, content=编辑邀请了13个审稿人但是半个月了无人接单。。大家都是多久有审稿人接单的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Fri Nov 01 14:28:26 CST 2024, time=2024-11-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205407, encodeId=8acd220540ec2, content=技术审查都一周了，还没到编辑那里，你们的多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38265396482, createdName=ms9000000045361890, createdTime=Sat May 18 21:20:40 CST 2024, time=2024-05-18, status=1, ipAttribution=安徽省)]

2024-11-07 非我来自陕西省

请问大家这个期刊如果审稿了，是不是大概率会接收？

85 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257331, encodeId=ab7e225e331f0, content=审稿速度:1.0 偏重的研究方向：心血管;糖尿病 经验分享：想问一下大家，这个文章外审后给了拒稿重投，还有必要大修完投回去吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1f6389102, createdName=ms1000000152514518, createdTime=Sat Mar 22 23:40:45 CST 2025, time=2025-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254269, encodeId=217322542692e, content=偏重的研究方向：心血管;糖尿病 经验分享：请问各位大佬，1）收到邮件通知文章接收，大概多久会收到支付版面费的邮件呢？2）另外，基金号不小心带错了，可以在校稿的时候修改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sun Mar 02 17:50:58 CST 2025, time=2025-03-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2144587, encodeId=c7a0214458e9d, content=有幸中了一篇，从投稿到接受1月零2天，整体比较顺，杂志对统计要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=667, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Sun Jun 25 09:03:13 CST 2023, time=2023-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198288, encodeId=bebf219828868, content=偏重的研究方向：代谢综合征 经验分享：请问各位大佬，peer review是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eb18429497, createdName=ms5000001142047044, createdTime=Sat Apr 13 15:04:33 CST 2024, time=2024-04-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2235750, encodeId=3a2d2235e506c, content=请问大家这个期刊如果审稿了，是不是大概率会接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/d5f470c5d4004705a6d8acee50b9c447-590mWyVcWjZT.jpg, createdBy=f66e9407848, createdName=非我, createdTime=Thu Nov 07 20:21:00 CST 2024, time=2024-11-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230586, encodeId=a70d2230586ed, content=审稿速度:1.0 经验分享：还愿来了，第一篇基础文章接受，投稿后几天通过技术检查，然后秒送外审，审稿一个月返回，审稿人没有让补实验，修回几天后就接收了。做的糖尿病心肌病+铁死亡，感觉是编辑比较认可文章，审稿人可能就是还行。祝大家好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Sun Oct 13 10:20:37 CST 2024, time=2024-10-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234559, encodeId=bf6b22345590e, content=编辑邀请了13个审稿人但是半个月了无人接单。。大家都是多久有审稿人接单的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Fri Nov 01 14:28:26 CST 2024, time=2024-11-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205407, encodeId=8acd220540ec2, content=技术审查都一周了，还没到编辑那里，你们的多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38265396482, createdName=ms9000000045361890, createdTime=Sat May 18 21:20:40 CST 2024, time=2024-05-18, status=1, ipAttribution=安徽省)]

2024-10-13 ms8000000757755021 来自江西省

审稿速度:1.0
经验分享：还愿来了，第一篇基础文章接受，投稿后几天通过技术检查，然后秒送外审，审稿一个月返回，审稿人没有让补实验，修回几天后就接收了。做的糖尿病心肌病+铁死亡，感觉是编辑比较认可文章，审稿人可能就是还行。祝大家好运。

75 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257331, encodeId=ab7e225e331f0, content=审稿速度:1.0 偏重的研究方向：心血管;糖尿病 经验分享：想问一下大家，这个文章外审后给了拒稿重投，还有必要大修完投回去吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1f6389102, createdName=ms1000000152514518, createdTime=Sat Mar 22 23:40:45 CST 2025, time=2025-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254269, encodeId=217322542692e, content=偏重的研究方向：心血管;糖尿病 经验分享：请问各位大佬，1）收到邮件通知文章接收，大概多久会收到支付版面费的邮件呢？2）另外，基金号不小心带错了，可以在校稿的时候修改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sun Mar 02 17:50:58 CST 2025, time=2025-03-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2144587, encodeId=c7a0214458e9d, content=有幸中了一篇，从投稿到接受1月零2天，整体比较顺，杂志对统计要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=667, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Sun Jun 25 09:03:13 CST 2023, time=2023-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198288, encodeId=bebf219828868, content=偏重的研究方向：代谢综合征 经验分享：请问各位大佬，peer review是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eb18429497, createdName=ms5000001142047044, createdTime=Sat Apr 13 15:04:33 CST 2024, time=2024-04-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2235750, encodeId=3a2d2235e506c, content=请问大家这个期刊如果审稿了，是不是大概率会接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/d5f470c5d4004705a6d8acee50b9c447-590mWyVcWjZT.jpg, createdBy=f66e9407848, createdName=非我, createdTime=Thu Nov 07 20:21:00 CST 2024, time=2024-11-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230586, encodeId=a70d2230586ed, content=审稿速度:1.0 经验分享：还愿来了，第一篇基础文章接受，投稿后几天通过技术检查，然后秒送外审，审稿一个月返回，审稿人没有让补实验，修回几天后就接收了。做的糖尿病心肌病+铁死亡，感觉是编辑比较认可文章，审稿人可能就是还行。祝大家好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Sun Oct 13 10:20:37 CST 2024, time=2024-10-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234559, encodeId=bf6b22345590e, content=编辑邀请了13个审稿人但是半个月了无人接单。。大家都是多久有审稿人接单的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Fri Nov 01 14:28:26 CST 2024, time=2024-11-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205407, encodeId=8acd220540ec2, content=技术审查都一周了，还没到编辑那里，你们的多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38265396482, createdName=ms9000000045361890, createdTime=Sat May 18 21:20:40 CST 2024, time=2024-05-18, status=1, ipAttribution=安徽省)]

2024-03-08 ms1000000262909438 来自湖北省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：糖尿病心血管
经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍

651 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257331, encodeId=ab7e225e331f0, content=审稿速度:1.0 偏重的研究方向：心血管;糖尿病 经验分享：想问一下大家，这个文章外审后给了拒稿重投，还有必要大修完投回去吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1f6389102, createdName=ms1000000152514518, createdTime=Sat Mar 22 23:40:45 CST 2025, time=2025-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254269, encodeId=217322542692e, content=偏重的研究方向：心血管;糖尿病 经验分享：请问各位大佬，1）收到邮件通知文章接收，大概多久会收到支付版面费的邮件呢？2）另外，基金号不小心带错了，可以在校稿的时候修改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sun Mar 02 17:50:58 CST 2025, time=2025-03-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2144587, encodeId=c7a0214458e9d, content=有幸中了一篇，从投稿到接受1月零2天，整体比较顺，杂志对统计要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=667, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Sun Jun 25 09:03:13 CST 2023, time=2023-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198288, encodeId=bebf219828868, content=偏重的研究方向：代谢综合征 经验分享：请问各位大佬，peer review是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eb18429497, createdName=ms5000001142047044, createdTime=Sat Apr 13 15:04:33 CST 2024, time=2024-04-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2235750, encodeId=3a2d2235e506c, content=请问大家这个期刊如果审稿了，是不是大概率会接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/d5f470c5d4004705a6d8acee50b9c447-590mWyVcWjZT.jpg, createdBy=f66e9407848, createdName=非我, createdTime=Thu Nov 07 20:21:00 CST 2024, time=2024-11-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230586, encodeId=a70d2230586ed, content=审稿速度:1.0 经验分享：还愿来了，第一篇基础文章接受，投稿后几天通过技术检查，然后秒送外审，审稿一个月返回，审稿人没有让补实验，修回几天后就接收了。做的糖尿病心肌病+铁死亡，感觉是编辑比较认可文章，审稿人可能就是还行。祝大家好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Sun Oct 13 10:20:37 CST 2024, time=2024-10-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234559, encodeId=bf6b22345590e, content=编辑邀请了13个审稿人但是半个月了无人接单。。大家都是多久有审稿人接单的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Fri Nov 01 14:28:26 CST 2024, time=2024-11-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205407, encodeId=8acd220540ec2, content=技术审查都一周了，还没到编辑那里，你们的多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38265396482, createdName=ms9000000045361890, createdTime=Sat May 18 21:20:40 CST 2024, time=2024-05-18, status=1, ipAttribution=安徽省)]

2024-05-08 ms8000001858743317 来自北京

请问大家现在是先校稿，再付版面费吗？

224 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257331, encodeId=ab7e225e331f0, content=审稿速度:1.0 偏重的研究方向：心血管;糖尿病 经验分享：想问一下大家，这个文章外审后给了拒稿重投，还有必要大修完投回去吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1f6389102, createdName=ms1000000152514518, createdTime=Sat Mar 22 23:40:45 CST 2025, time=2025-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254269, encodeId=217322542692e, content=偏重的研究方向：心血管;糖尿病 经验分享：请问各位大佬，1）收到邮件通知文章接收，大概多久会收到支付版面费的邮件呢？2）另外，基金号不小心带错了，可以在校稿的时候修改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sun Mar 02 17:50:58 CST 2025, time=2025-03-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2144587, encodeId=c7a0214458e9d, content=有幸中了一篇，从投稿到接受1月零2天，整体比较顺，杂志对统计要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=667, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Sun Jun 25 09:03:13 CST 2023, time=2023-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198288, encodeId=bebf219828868, content=偏重的研究方向：代谢综合征 经验分享：请问各位大佬，peer review是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eb18429497, createdName=ms5000001142047044, createdTime=Sat Apr 13 15:04:33 CST 2024, time=2024-04-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2235750, encodeId=3a2d2235e506c, content=请问大家这个期刊如果审稿了，是不是大概率会接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/d5f470c5d4004705a6d8acee50b9c447-590mWyVcWjZT.jpg, createdBy=f66e9407848, createdName=非我, createdTime=Thu Nov 07 20:21:00 CST 2024, time=2024-11-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230586, encodeId=a70d2230586ed, content=审稿速度:1.0 经验分享：还愿来了，第一篇基础文章接受，投稿后几天通过技术检查，然后秒送外审，审稿一个月返回，审稿人没有让补实验，修回几天后就接收了。做的糖尿病心肌病+铁死亡，感觉是编辑比较认可文章，审稿人可能就是还行。祝大家好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Sun Oct 13 10:20:37 CST 2024, time=2024-10-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234559, encodeId=bf6b22345590e, content=编辑邀请了13个审稿人但是半个月了无人接单。。大家都是多久有审稿人接单的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Fri Nov 01 14:28:26 CST 2024, time=2024-11-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205407, encodeId=8acd220540ec2, content=技术审查都一周了，还没到编辑那里，你们的多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38265396482, createdName=ms9000000045361890, createdTime=Sat May 18 21:20:40 CST 2024, time=2024-05-18, status=1, ipAttribution=安徽省)]

2024-11-01 ms9000002057290162 来自浙江省

编辑邀请了13个审稿人但是半个月了无人接单。。大家都是多久有审稿人接单的啊

70 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257331, encodeId=ab7e225e331f0, content=审稿速度:1.0 偏重的研究方向：心血管;糖尿病 经验分享：想问一下大家，这个文章外审后给了拒稿重投，还有必要大修完投回去吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1f6389102, createdName=ms1000000152514518, createdTime=Sat Mar 22 23:40:45 CST 2025, time=2025-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254269, encodeId=217322542692e, content=偏重的研究方向：心血管;糖尿病 经验分享：请问各位大佬，1）收到邮件通知文章接收，大概多久会收到支付版面费的邮件呢？2）另外，基金号不小心带错了，可以在校稿的时候修改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sun Mar 02 17:50:58 CST 2025, time=2025-03-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2144587, encodeId=c7a0214458e9d, content=有幸中了一篇，从投稿到接受1月零2天，整体比较顺，杂志对统计要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=667, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Sun Jun 25 09:03:13 CST 2023, time=2023-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198288, encodeId=bebf219828868, content=偏重的研究方向：代谢综合征 经验分享：请问各位大佬，peer review是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4eb18429497, createdName=ms5000001142047044, createdTime=Sat Apr 13 15:04:33 CST 2024, time=2024-04-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2235750, encodeId=3a2d2235e506c, content=请问大家这个期刊如果审稿了，是不是大概率会接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/d5f470c5d4004705a6d8acee50b9c447-590mWyVcWjZT.jpg, createdBy=f66e9407848, createdName=非我, createdTime=Thu Nov 07 20:21:00 CST 2024, time=2024-11-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230586, encodeId=a70d2230586ed, content=审稿速度:1.0 经验分享：还愿来了，第一篇基础文章接受，投稿后几天通过技术检查，然后秒送外审，审稿一个月返回，审稿人没有让补实验，修回几天后就接收了。做的糖尿病心肌病+铁死亡，感觉是编辑比较认可文章，审稿人可能就是还行。祝大家好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Sun Oct 13 10:20:37 CST 2024, time=2024-10-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234559, encodeId=bf6b22345590e, content=编辑邀请了13个审稿人但是半个月了无人接单。。大家都是多久有审稿人接单的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Fri Nov 01 14:28:26 CST 2024, time=2024-11-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205407, encodeId=8acd220540ec2, content=技术审查都一周了，还没到编辑那里，你们的多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38265396482, createdName=ms9000000045361890, createdTime=Sat May 18 21:20:40 CST 2024, time=2024-05-18, status=1, ipAttribution=安徽省)]

2024-05-18 ms9000000045361890 来自安徽省

技术审查都一周了，还没到编辑那里，你们的多久

152 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务